These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26308056)

  • 1. The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain.
    Singer BJ; Silbert BI; Silbert PL; Singer KP
    Toxins (Basel); 2015 Aug; 7(9):3388-404. PubMed ID: 26308056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open label pilot investigation of the efficacy of Botulinum toxin type A [Dysport] injection in the rehabilitation of chronic anterior knee pain.
    Singer BJ; Silbert PL; Dunne JW; Song S; Singer KP
    Disabil Rehabil; 2006 Jun; 28(11):707-13. PubMed ID: 16809213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior knee pain caused by patellofemoral pain syndrome can be relieved by Botulinum toxin type A injection.
    Chen JT; Tang AC; Lin SC; Tang SF
    Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S27-9. PubMed ID: 25683309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Botulinim toxin type-A injection in the management of anterior knee pain.
    Singer BJ; Singer KP
    Clin Neurol Neurosurg; 2015 Dec; 139():95. PubMed ID: 26409182
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin type A for nonsurgical lateral release in patellofemoral pain syndrome: a case study.
    Drake DF; Pidcoe PE; Ericksen J
    Mil Med; 2011 Jun; 176(6):696-8. PubMed ID: 21702391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial.
    Singer BJ; Silbert PL; Song S; Dunne JW; Singer KP
    Br J Sports Med; 2011 Jun; 45(8):640-5. PubMed ID: 20418523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial.
    Najafi S; Sanati E; Khademi M; Abdorrazaghi F; Mofrad RK; Rezasoltani Z
    Toxicon; 2019 Jul; 165():69-77. PubMed ID: 30995453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Sonographically Guided Botulinum Toxin Type A (Dysport) Injections Into the Tensor Fasciae Latae for the Treatment of Lateral Patellofemoral Overload Syndrome.
    Stephen JM; Urquhart DW; van Arkel RJ; Ball S; Jaggard MK; Lee JC; Church JS
    Am J Sports Med; 2016 May; 44(5):1195-202. PubMed ID: 26903213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enduring efficacy of Botulinum toxin type A injection for refractory anterior knee pain.
    Silbert BI; Singer BJ; Silbert PL; Gibbons JT; Singer KP
    Disabil Rehabil; 2012; 34(1):62-8. PubMed ID: 21936736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for the treatment of musculoskeletal pain and spasm.
    Sheean G
    Curr Pain Headache Rep; 2002 Dec; 6(6):460-9. PubMed ID: 12413405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of refractory pain with botulinum toxins--an evidence-based review.
    Jabbari B; Machado D
    Pain Med; 2011 Nov; 12(11):1594-606. PubMed ID: 21958302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study.
    Babcock MS; Foster L; Pasquina P; Jabbari B
    Am J Phys Med Rehabil; 2005 Sep; 84(9):649-54. PubMed ID: 16141740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged vastus lateralis denervation after botulinum toxin type A injection.
    Dunne JW; Singer BJ; Silbert PL; Singer KP
    Mov Disord; 2010 Feb; 25(3):397-401. PubMed ID: 20108381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injection to facilitate rehabilitation of muscle imbalance syndromes in sports medicine.
    Cullen DM; Boyle JJ; Silbert PL; Singer BJ; Singer KP
    Disabil Rehabil; 2007 Dec; 29(23):1832-9. PubMed ID: 18033608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.
    Yoon SJ; Ho J; Kang HY; Lee SH; Kim KI; Shin WG; Oh JM
    Pharmacotherapy; 2007 May; 27(5):657-65. PubMed ID: 17461700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.
    Yelnik AP; Colle FM; Bonan IV; Vicaut E
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):845-8. PubMed ID: 17088333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.